C1q and central nervous system disorders

被引:22
|
作者
Zhang, Wenjie [1 ,2 ]
Chen, Yuan [3 ]
Pei, Hui [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency, Intens Care Unit, Zhengzhou, Peoples R China
[2] Xingyang Sishui Cent Hlth Ctr, Dept Gen Practice, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
c1q; central nervous system; neurodevelopment; degenerative diseases; inflammatory diseases; glioma; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; COMPLEMENT PROTEIN C1Q; MOUSE MODEL; SPINAL-CORD; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; PATHWAY ACTIVATION; CLASSICAL PATHWAY; UP-REGULATION;
D O I
10.3389/fimmu.2023.1145649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C1q is a crucial component of the complement system, which is activated through the classical pathway to perform non-specific immune functions, serving as the first line of defense against pathogens. C1q can also bind to specific receptors to carry out immune and other functions, playing a vital role in maintaining immune homeostasis and normal physiological functions. In the developing central nervous system (CNS), C1q functions in synapse formation and pruning, serving as a key player in the development and homeostasis of neuronal networks in the CNS. C1q has a close relationship with microglia and astrocytes, and under their influence, C1q may contribute to the development of CNS disorders. Furthermore, C1q can also have independent effects on neurological disorders, producing either beneficial or detrimental outcomes. Most of the evidence for these functions comes from animal models, with some also from human specimen studies. C1q is now emerging as a promising target for the treatment of a variety of diseases, and clinical trials are already underway for CNS disorders. This article highlights the role of C1q in CNS diseases, offering new directions for the diagnosis and treatment of these conditions.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Ion Channels as Drug Targets in Central Nervous System Disorders
    Waszkielewicz, A. M.
    Gunia, A.
    Szkaradek, N.
    Sloczynska, K.
    Krupinska, S.
    Marona, H.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (10) : 1241 - 1285
  • [22] Advances in the study of polydopamine nanotechnology in central nervous system disorders
    Ren, Sijing
    Xiao, Xiangyu
    Lv, Jiahua
    Lv, Shaomin
    Wang, Xingchen
    Liu, Ruihan
    Kong, Qing-xia
    FRONTIERS IN MATERIALS, 2024, 11
  • [23] The gut microbiota and its correlations with the central nervous system disorders
    Catanzaro, R.
    Anzalone, M. G.
    Calabrese, F.
    Milazzo, M.
    Capuana, M. L.
    Italia, A.
    Occhipinti, S.
    Marotta, F.
    PANMINERVA MEDICA, 2015, 57 (03) : 127 - 143
  • [24] C1q deficiency in an Inuit family: Identification of a new class of C1q disease-causing mutations
    Marquart, Hanne Vibeke
    Schejbel, Lone
    Sjoholm, Anders
    Martensson, Ulla
    Nielsen, Susan
    Koch, Anders
    Svejgaard, Arne
    Garred, Peter
    CLINICAL IMMUNOLOGY, 2007, 124 (01) : 33 - 40
  • [25] A Review of Proliferative Vascular Disorders of the Central Nervous System of Animals
    Marr, Jacqueline
    Miranda, Ileana C.
    Miller, Andrew D.
    Summers, Brian A.
    VETERINARY PATHOLOGY, 2021, 58 (05) : 864 - 880
  • [26] Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders
    Moretti, Rita
    Giuffre, Mauro
    Merli, Nicola
    Caruso, Paola
    Di Bella, Stefano
    Tiribelli, Claudio
    Croce, Lory Saveria
    BRAIN SCIENCES, 2021, 11 (12)
  • [27] MTH1 in the disorders of the central nervous system: scope beyond brain tumors and challenges
    Padmakumar, Lekshmi
    Menon, Ramshekhar N.
    Gopala, Srinivas
    Vilanilam, George C.
    ACTA NEUROLOGICA BELGICA, 2025,
  • [28] Central nervous system manifestations of mitochondrial disorders
    Finsterer, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (04): : 217 - 238
  • [29] Headache and inflammatory disorders of the central nervous system
    La Mantia, L
    Erbetta, A
    NEUROLOGICAL SCIENCES, 2004, 25 (Suppl 3) : S148 - S153
  • [30] The Use of Flavonoids in Central Nervous System Disorders
    Grosso, C.
    Valentao, P.
    Ferreres, F.
    Andrade, P. B.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (37) : 4694 - 4719